How serious is FDA warning about revolutionary blood-cancer
Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.
Studying use of patients' own reprogrammed cells to attack cancer as alternative to more chemo
CAR-T Therapy: The Future of Regenerative Immunotherapy - OriGen Biomedical
/wp-content/uploa
Your Cholesterol Test Might Not Be FDA Approved. The Agency Wants to Change That. - WSJ
James Wang, PhD on LinkedIn: Kite releases pivotal CAR T therapy Phase III study results
Tracie-Jo (TJ) Crowthers on LinkedIn: #thankyou #project #recruiter #scienceandtechnology #biotechnology…
Oncology Health Central
Mark Flower on LinkedIn: #celltherapy #cryopreservation #apheresis #donoridentification…
Taking Stock of CAR T-Cell Therapy